Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization277 mentions
- NVIDIAorganization265 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
WuXi Biologics
organization6 mentionslast seen Nov 4, 2026
A leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions for biologics discovery, development and manufacturing.
Relationships 37
- WuXi BiologicsemploysChris Chen99% confidence5 sources
- WuXi Biologicsconforms toMorningstar Sustainalytics Negligible Risk Rating99% confidence2 sources
- WuXi Biologicsconforms toDow Jones Best-in-Class World Index99% confidence2 sources
- WuXi Biologicsconforms toEcoVadis Platinum Medal99% confidence2 sources
- WuXi BiologicsdevelopsGreen CRDMO99% confidence2 sources
- WuXi Biologicsconforms toHang Seng Corporate Sustainability Benchmark Index95% confidence1 source
- WuXi Biologicsconforms toHang Seng ESG 50 Index95% confidence1 source
- WuXi Biologicsconforms toFTSE4Good Index Series93% confidence1 source
- WuXi Biologicsconforms toCDP Supplier Engagement Assessment A List93% confidence1 source
- WuXi Biologicsconforms toCDP A List for Water Security93% confidence1 source
- WuXi Biologicsconforms toDow Jones Best-in-Class Emerging Markets Index93% confidence1 source
- WuXi Biologicsconforms toCDP A List for Climate Change93% confidence1 source
- WuXi Biologicsconforms toMSCI ESG Rating93% confidence1 source
- WuXi BiologicsdevelopsWuXia TrueSite93% confidence1 source
- WuXi Biologicsconforms toScience Based Targets initiative93% confidence1 source
- WuXi BiologicsdevelopsWuXiHigh 2.093% confidence1 source
- WuXi Biologicsconforms toFDA GMP92% confidence1 source
- U.S. Food and Drug AdministrationapprovesWuXi Biologics92% confidence1 source
- WuXi BiologicsdevelopsWuXiBody bispecific antibody platform90% confidence1 source
- WuXi BiologicsdevelopsWuXiUI ultra-intensified fed-batch production technology platform90% confidence1 source
- European Medicines AgencyapprovesWuXi Biologics90% confidence1 source
- WuXi BiologicsownsWuXi Biologics Dundalk90% confidence1 source
- WuXi Biologicsconforms toUnited Nations Sustainable Development Goals90% confidence1 source
- WuXi BiologicsdevelopsGreen CRDMO solution90% confidence1 source
- WuXi BiologicsownsWuXi Biologics Wuppertal90% confidence1 source
- WuXi BiologicsdevelopsSmart ESG platform90% confidence1 source
- WuXi BiologicsdevelopsGlobal Dual Sourcing88% confidence1 source
- WuXi Biologicsdevelopsdigital Smart ESG management platform88% confidence1 source
- Hang Seng Indexes CompanyapprovesWuXi Biologics85% confidence1 source
- WuXi Biologicsconforms toScience Based Targets initiative GHG emission reduction targets85% confidence1 source
- WuXi BiologicsdevelopsCRDMO platform85% confidence1 source
- WuXi Biologicsdevelopssingle-use technology for biologics manufacturing85% confidence1 source
- WuXi Biologicsconforms toMSCI AAA rating85% confidence1 source
- WuXi Biologicsdevelopsmonoclonal antibody75% confidence1 source
- WuXi Biologicsdevelopsfusion protein75% confidence1 source
- WuXi Biologicsdevelopsbispecific antibody75% confidence1 source
- WuXi Biologicsdevelopsenzyme75% confidence1 source
Relationship
WuXi Biologicsconforms toHang Seng ESG 50 Index
95% confidence1 supporting mentions
Either name opens that entity’s relationships.
Sources 1